21. Федеральный закон «О качестве и безопасности пищевых продуктов» от 02.01.2000 г. № 29-ФЗ [Federal Law «On Quality and Safety of Foodstuffs» of 02.01.2000, No. 29-FZ(In Russ.)] URL: https://rg.ru/2000/01/02/ produkty-dok.html.
22. Федеральный закон от 01.03.2020 г. № 47-ФЗ «О внесении изменений в Федеральный закон «О качестве и безопасности пищевых продуктов» и статью 37 Федерального закона «Об образовании в Российской Федерации» [Federal Law No. 47-FZ of 01.03.2020 “On Amendments to the Federal Law ‘On Quality and Safety of Foodstuffs’ and Article 37 of the Federal Law ‘On Education in the Russian Federation’” (In Russ.)] URL: https:// rg.ru/2020/03/03/pitanie-dok.html.
23. ГОСТ Р 55577-2013. Национальный стандарт Российской Федерации. Продукты пищевые специализированные и функциональные. Информация об отличительных признаках и эффективности. [GOST P 55577-2013. National Standard of the Russian Federation. Specialised and functional food products. Information on distinguishing characters and efficacy (In Russ.)] URL: https:// internet-law.ru/gosts/gost/55874/
24. ГОСТ Р 54059-2010. Национальный стандарт Российской Федерации. Продукты пищевые функциональные. Ингредиенты пищевые функциональные. Классификация и общие требования. [GOST R 54059-2010. National Standard of the Russian Federation. Functional food products. Functional food ingredients. Classification and general requirements (In Russ.)] URL: https://internet-law. ru/gosts/gost/50895/
25. Shi L.H., Balakrishnan K., Thiagarajah K., Mohd Ismail N.I., Yin O.S. Beneficial Properties of Probiotics. Trop Life Sci Res. 2016;27(2):73–90. DOI: 10.21315/ tlsr2016.27.2.6
26. Ishibashi N., Yamazaki S. Probiotics and safety. Am J Clin Nutr. 2001;73(2 Suppl):465S–470. DOI: 10.1093/ ajcn/73.2.465s
27. de Vos P., Faas M.M., Spasojevic M.M., Sikkema J. Encapsulation for preservation of functionality and targeted delivery of bioactive food components. Int Dairy J. 2010;20:292–302. DOI: 10.1016/j.idairyj.2009.11.008
28. Burgain J., Gaiani C., Linder M., Scher J. Encapsulation of probiotic living cells: from laboratory scale to industrial applications. J Food Eng. 2011;104:467–83. DOI: 10.1016/j.jfoodeng.2010.12.031
29. Salas-Jara M., Ilabaca A., Vega M., García A. Biofilm forming Lactobacillus: new challenges for the development of probiotics. Microorganisms. 2016;4(3):35. DOI: 10.3390/microorganisms4030035
30. Tsai Y.L., Lin T.L., Chang C.J., Wu T.R., Lai W.F., Lu C.C., Lai H.C. Probiotics, prebiotics and amelioration of diseases. J Biomed Sci. 2019;26(1):3. DOI: 10.1186/ s12929-018-0493-6
31. Howick J., Chalmers I., Glasziou P., Greenhalgh T., Heneghan C., Liberati A., et al. Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document). Oxford Centre for Evidence-Based Medicine. https://www.cebm. net/index.aspx?o=5653
32. Allen S.J., Martinez E.G., Gregorio G.V., Dans L.F. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010;(11):CD003048. DOI: 10.1002/14651858.CD003048.pub3
33. Höchter W., Hagenhoff G. Saccharomyces boulardii in acute adult diarrhea: efficacy and tolerability of treatment. Munch Med Wochenschr. 1990;(132):188–92.
34. Grossi E., Buresta R., Abbiati R., Cerutti R., Pro-DIA study group. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with acute diarrhea: a multicenter, randomized study in primary care. J Clin Gastroenterol. 2010;44 Suppl 1:S35–41. DOI: 10.1097/ MCG.0b013e3181e103f4
35. Hempel S., Newberry S.J., Maher A.R., Wang Z., Miles J.N.V., Shanman R., et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307(18):1959–69. DOI: 10.1001/jama.2012.3507
36. Ouwehand A.C., Dong-Lian C., Weijian X., Ste wart M., Ni J., Stewart T., et al. Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study. Vaccine. 2014;32(4):458–63
37. Chatterjee S., Kar P., Das T., Ray S., Gangulyt S., Rajendiran C., et al. Randomised placebocontrolled double blind multicenteric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea. J Assoc Physicians India. 2013;61(10):708–12.
38. Hickson M., D’Souza A.L., Muthu N., Rogers T.R., Want S., Rajkumar C., et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007;335(7610):80. DOI: 10.1136/bmj.39231.599815.55
39. Cimperman L., Bayless G., Best K., Diligente A., Mordarski B., Oster M., et al. A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J Clin Gastroenterol. 2011;45(9):785– 9. DOI: 10.1097/MCG.0b013e3182166a42
40. Goldenberg J.Z., Yap C., Lytvyn L., Lo C.K., Beardsley J., Mertz D., et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5:CD006095. DOI: 10.1002/14651858.CD006095.pub4
41. Lewis S., Burmeister S., Brazier J. Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. Clin Gastroenterol Hepatol. 2005;3(5):442–8. DOI: 10.1016/s1542- 3565(04)00677-9
42. Shi X., Zhang J., Mo L., Shi J., Qin M., Huang X. Efficacy and safety of probiotics in eradicating Helicobacter pylori. A network meta-analysisMedicine (Baltimore). 2019;98(15):e15180. DOI: 10.1097/ MD.0000000000015180
43. Dang Y., Reinhardt J.D., Zhou X., Zhang G. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis. PloS One. 2014;9(11):e111030. DOI: 10.1371/journal.pone.0111030